Senate Bill 716
Prohibiting step therapy protocols for certain cancer drugs
Stopped in committee
It never got a , so it never came up for a vote. To try again, a lawmaker would have to start a new bill.
-
Introduced, passed
Nov 19, 2021
-
Committee, stopped here
Stopped here. No public hearing was held.
-
Senate vote, not reached
-
Assembly vote, not reached
-
Governor, not reached
-
Law, not reached
Latest entry in the official record, Mar 15, 2022: “Failed to pass pursuant to ”
It never got a hearing in the Senate Committee on Insurance, Licensing and Forestry. See every bill that never got a hearing this session.
Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.
Terms on this page
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Public hearing
A meeting where anyone can speak to a committee about a bill, or send written comments.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1. More in the glossary
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis. More in the glossary
Author
A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.
Official term: Author, coauthor. More in the glossary
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor. More in the glossary
What it would have done
Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.
This bill prohibits an insurer, pharmacy benefit manager, or utilization review organization from requiring a step therapy protocol for a drug that is prescribed for metastatic cancer or a cancer-associated condition and the use of the drug is approved by the federal Food and Drug Administration, consistent with best practices for the treatment of metastatic cancer or the cancer-associated condition, and supported by peer-reviewed publications that are based on evidence-based research. A step therapy protocol, as defined in current law, establishes a specific sequence in which medically appropriate prescription drugs are covered by a policy or plan. Current law requires insurers, pharmacy benefit managers, and utilization review organizations to use clinical review criteria for establishing a step therapy protocol that are based on clinical practice guidelines that meet certain specific criteria and to provide access to a process to request an exception to the step therapy protocol.
Who's behind it
4 senators are its . All 4 are Democrats.
15 more lawmakers .
See all 19 names Hide the names
Authors (4)
- Melissa Agard · Democrat, Senate
- Chris Larson · Democrat, Senate
- Janis Ringhand · Democrat, Senate
- Jeff Smith · Democrat, Senate
Signed on in support (15)
- Deb Andraca · Democrat, Assembly
- Sue Conley · Democrat, Assembly
- Steve Doyle · Democrat, Assembly
- Gary Hebl · Democrat, Assembly
- Dianne Hesselbein · Democrat, Senate
- Tod Ohnstad · Democrat, Assembly
- Sondy Pope · Democrat, Assembly
- Sara Rodriguez · Democrat, Assembly
- Katrina Shankland · Democrat, Assembly
- Christine Sinicki · Democrat, Assembly
- Lee Snodgrass · Democrat, Assembly
- Mark Spreitzer · Democrat, Senate
- Lisa Subeck · Democrat, Assembly
- Ron Tusler · Republican, Assembly
- Don Vruwink · Democrat, Assembly
What happened
-
Mar 15, 2022
The session ended, and the bill died with it.
-
Feb 11, 2022 to Feb 15, 2022
2 more representatives signed on in support.
-
Nov 19, 2021
Sent to the Senate Committee on Insurance, Licensing and Forestry.
-
Nov 19, 2021
Introduced in the Senate.
See the official record, word for word Hide the official record
- Nov 19, 2021 · Senate
Introduced by Senators Ringhand, Agard, Larson and Smith; cosponsored by Representatives Subeck, S. Rodriguez, Conley, Doyle, Hebl, Hesselbein, Ohnstad, Pope, Shankland, Sinicki, Snodgrass, Tusler and Vruwink
- Nov 19, 2021 · Senate
Read first time and referred to Committee on Insurance, Licensing and Forestry
- Feb 11, 2022 · Senate
Representative Spreitzer added as a cosponsor
- Feb 15, 2022 · Senate
Representative Andraca added as a cosponsor
- Mar 15, 2022 · Senate
Failed to pass pursuant to Senate Joint Resolution 1
Terms on this page
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Public hearing
A meeting where anyone can speak to a committee about a bill, or send written comments.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1. More in the glossary
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis. More in the glossary
Author
A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.
Official term: Author, coauthor. More in the glossary
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor. More in the glossary
From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Public hearing
A meeting where anyone can speak to a committee about a bill, or send written comments.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor